GM1型2型神经节苷脂病一例模拟Zellweger综合征

N. R. Ganampet, P. J. Charpuria, P. C. Chemudupati Parven, Shresta Mary K, Dirgha Patel, Smaran Kasireddy
{"title":"GM1型2型神经节苷脂病一例模拟Zellweger综合征","authors":"N. R. Ganampet, P. J. Charpuria, P. C. Chemudupati Parven, Shresta Mary K, Dirgha Patel, Smaran Kasireddy","doi":"10.34257/gjmravol23is3pg21","DOIUrl":null,"url":null,"abstract":"Juvenile GM1-gangliosidosis, also known as type II or juvenile GM1-gangliosidosis, is an autosomal recessive lysosomal storage disorder that clinically differs from infantile GM1-gangliosidosis in the absence of the characteristic cherry-red patch and hepatosplenomegaly. The disease is characterized by mild skeletal abnormalities and slowly progressing neurodegeneration. Due to the late age of onset and unusual presentation, diagnostic confusion with other ataxic and purely neurological disorders is common. There are currently 3–4 recognized types of GM1-gangliosidosis, with type I being the most prevalent phenotype with an average onset age of 6 months. Several subtypes of GM1-gangliosidosis are caused by mutations in the GLB1 gene, but the location and type of deleterious mutations have a direct impact on the severity of the disease and the age at which it manifests. A fully immunized 8-month-old male presented to our hospital with complaints of mild feeding difficulty, periorbital edema, and fever. Facial dysmorphism, hypotonia, delayed development, and hepatomegaly were observed in the patient. As there is currently no effective treatment for GM1 gangliosidosis, the carrier of the disease receives only symptomatic and palliative care. Given that genetic counseling is now the only means of preventing the disease, early diagnosis is crucial.","PeriodicalId":93101,"journal":{"name":"Global journal of medical research","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A Case of GM 1 Gangliosidosis Type 2 Mimicking Zellweger Syndrome\",\"authors\":\"N. R. Ganampet, P. J. Charpuria, P. C. Chemudupati Parven, Shresta Mary K, Dirgha Patel, Smaran Kasireddy\",\"doi\":\"10.34257/gjmravol23is3pg21\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Juvenile GM1-gangliosidosis, also known as type II or juvenile GM1-gangliosidosis, is an autosomal recessive lysosomal storage disorder that clinically differs from infantile GM1-gangliosidosis in the absence of the characteristic cherry-red patch and hepatosplenomegaly. The disease is characterized by mild skeletal abnormalities and slowly progressing neurodegeneration. Due to the late age of onset and unusual presentation, diagnostic confusion with other ataxic and purely neurological disorders is common. There are currently 3–4 recognized types of GM1-gangliosidosis, with type I being the most prevalent phenotype with an average onset age of 6 months. Several subtypes of GM1-gangliosidosis are caused by mutations in the GLB1 gene, but the location and type of deleterious mutations have a direct impact on the severity of the disease and the age at which it manifests. A fully immunized 8-month-old male presented to our hospital with complaints of mild feeding difficulty, periorbital edema, and fever. Facial dysmorphism, hypotonia, delayed development, and hepatomegaly were observed in the patient. As there is currently no effective treatment for GM1 gangliosidosis, the carrier of the disease receives only symptomatic and palliative care. Given that genetic counseling is now the only means of preventing the disease, early diagnosis is crucial.\",\"PeriodicalId\":93101,\"journal\":{\"name\":\"Global journal of medical research\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-08-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Global journal of medical research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.34257/gjmravol23is3pg21\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Global journal of medical research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.34257/gjmravol23is3pg21","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

幼年型gm1神经节脂质沉积症,也称为II型或幼年型gm1神经节脂质沉积症,是一种常染色体隐性溶酶体贮积症,临床上与婴儿型gm1神经节脂质沉积症不同,没有特征性的樱桃红色斑块和肝脾肿大。这种疾病的特征是轻微的骨骼异常和缓慢进展的神经变性。由于发病年龄晚,表现不寻常,与其他共济失调和纯粹神经系统疾病的诊断混淆是常见的。目前公认的gm1神经节脂质病有3-4种类型,其中I型为最常见的表型,平均发病年龄为6个月。gm1神经节脂质沉积症的几种亚型是由GLB1基因突变引起的,但有害突变的位置和类型对疾病的严重程度和表现年龄有直接影响。一名8月龄男性患者,经全面免疫后,以轻度进食困难、眶周水肿及发热就诊。患者表现为面部畸形、肌张力低下、发育迟缓、肝肿大。由于目前没有针对GM1神经节脂质病的有效治疗方法,该疾病的携带者只能接受对症治疗和姑息治疗。鉴于遗传咨询是目前预防这种疾病的唯一手段,早期诊断至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
A Case of GM 1 Gangliosidosis Type 2 Mimicking Zellweger Syndrome
Juvenile GM1-gangliosidosis, also known as type II or juvenile GM1-gangliosidosis, is an autosomal recessive lysosomal storage disorder that clinically differs from infantile GM1-gangliosidosis in the absence of the characteristic cherry-red patch and hepatosplenomegaly. The disease is characterized by mild skeletal abnormalities and slowly progressing neurodegeneration. Due to the late age of onset and unusual presentation, diagnostic confusion with other ataxic and purely neurological disorders is common. There are currently 3–4 recognized types of GM1-gangliosidosis, with type I being the most prevalent phenotype with an average onset age of 6 months. Several subtypes of GM1-gangliosidosis are caused by mutations in the GLB1 gene, but the location and type of deleterious mutations have a direct impact on the severity of the disease and the age at which it manifests. A fully immunized 8-month-old male presented to our hospital with complaints of mild feeding difficulty, periorbital edema, and fever. Facial dysmorphism, hypotonia, delayed development, and hepatomegaly were observed in the patient. As there is currently no effective treatment for GM1 gangliosidosis, the carrier of the disease receives only symptomatic and palliative care. Given that genetic counseling is now the only means of preventing the disease, early diagnosis is crucial.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信